Zahra Rikhtegaran Tehrani
Overview
Explore the profile of Zahra Rikhtegaran Tehrani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sajadi M, Abbasi A, Tehrani Z, Siska C, Clark R, Chi W, et al.
bioRxiv
. 2024 Oct;
PMID: 39464103
Anti-HIV envelope broadly neutralizing antibodies (bnAbs) are alternatives to conventional antiretrovirals with the potential to prevent and treat infection, reduce latent reservoirs, and/or mediate a functional cure. Clinical trials with...
2.
Atkinson B, Abassi A, Sajadi M, Tehrani Z, Le N, Chen H, et al.
AIDS Res Hum Retroviruses
. 2023 Apr;
39(9):475-481.
PMID: 37053110
Non-small cell lung cancer (NSCLC) is the most fatal non-AIDS defining cancer in people living with HIV (PWH) on antiretroviral therapy (ART). Treatment of malignancies in PWH requires concomitant cancer...
3.
Sajadi M, Shokatpour N, Purcell M, Tehrani Z, Lankford A, Bathula A, et al.
PLoS One
. 2023 Apr;
18(4):e0284020.
PMID: 37023025
Background: Although there have been many studies on antibody responses to SARS-CoV-2 in breast milk, very few have looked at the fate of these in the infant, and whether they...
4.
Sajadi M, Myers A, Logue J, Saadat S, Shokatpour N, Quinn J, et al.
mSphere
. 2022 Nov;
7(6):e0027922.
PMID: 36321826
With much of the world infected with or vaccinated against severe acute respiratory syndrome coronavirus 2 (commonly abbreviated SARS-CoV-2; abbreviated here SARS2), understanding the immune responses to the SARS2 spike...
5.
Tehrani Z, Sajadi M
JAMA Netw Open
. 2021 Nov;
4(11):e2133012.
PMID: 34726751
No abstract available.
6.
Hastie K, Li H, Bedinger D, Schendel S, Dennison S, Li K, et al.
Science
. 2021 Sep;
374(6566):472-478.
PMID: 34554826
Antibody-based therapeutics and vaccines are essential to combat COVID-19 morbidity and mortality after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Multiple mutations in SARS-CoV-2 that could impair antibody defenses...
7.
Tolbert W, Nguyen D, Tehrani Z, Sajadi M, Pazgier M
mBio
. 2021 Jul;
12(4):e0127421.
PMID: 34281393
The first step in HIV-1 entry is the attachment of the envelope (Env) trimer to target cell CD4. As such, the CD4-binding site (CD4bs) remains one of the few universally...
8.
Saadat S, Tehrani Z, Logue J, Newman M, Frieman M, Harris A, et al.
JAMA
. 2021 Mar;
325(14):1467-1469.
PMID: 33646292
No abstract available.
9.
Tehrani Z, Saadat S, Saleh E, Ouyang X, Constantine N, DeVico A, et al.
PLoS One
. 2020 Nov;
15(11):e0237828.
PMID: 33137138
There is an urgent need for an accurate antibody test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We have developed 3 ELISA methods, trimer spike IgA, trimer spike IgG,...
10.
Saadat S, Pezhman Karami , Jafari M, Kholoujini M, Tehrani Z, Mohammadi Y, et al.
Pathog Dis
. 2020 Sep;
78(7).
PMID: 32940669
Background: Mycoplasma hominis, an opportunistic pathogen in human genitourinary tract, can cause chronic infection in the prostate. Intracellular survival of M. hominis leads to a prolonged presence in the host...